FY 2017
***
***
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements.
Book Marcinko: https://medicalexecutivepost.com/dr-david-marcinkos-bookings/
Subscribe: MEDICAL EXECUTIVE POST for curated news, essays, opinions and analysis from the public health, economics, finance, marketing, IT, business and policy management ecosystem.
***
Filed under: Drugs and Pharma | Tagged: Prescription Drug Spending for Commercial Plans, www.MCOL.com |















Prescription Drug Spending Will Average 6.3% Growth From 2017-2026
The CMS Office of the Actuary recently released national health expenditure projections up to 2026. Here are some key findings from the report:
• The insured population is projected to decrease from 91.1% in 2016 to 89.3% in 2026.
• Spending growth is projected to average 6.3% for prescription drugs from 2017-2026.
• Over 2017-2026, growth in personal healthcare spending is projected to average 5.5%.
• Medicaid is projected to average 5.8% annual growth over 2017-2026.
• Private health insurance spending is projected to average 4.7% over 2017-2026.
• Medicare is projected to experience 7.4% spending growth from 2017-2026.
Source: CMS, February 14, 2018
LikeLike